Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Atopic Dermatitis Industry By 2029?
The atopic dermatitis sector has experienced rapid growth in recent years. Its market size is projected to rise from $8.61 billion in 2024 to $9.88 billion in 2025 with a compound annual growth rate (CAGR) of 14.7%. The expansion during the historical period could be traced back to growing medical knowledge and awareness, rates of incidence and prevalence, patient advocacy and support, evolution of treatment options, and research and development.
In the forthcoming years, swift expansion is predicted in the atopic dermatitis market segment, with estimations suggesting an increase to $17.08 billion in 2029, reflecting a compound annual growth rate (CAGR) of 14.7%. This anticipated growth during this period is primarily due to developments in biologic therapies, immunomodulators, small molecule drugs, pediatric-targeted treatments, gene therapy, and precision medicine as well as the incorporation of digital health. Prevailing trends predicted for this period include advancements in topical technology, a sharper focus on pediatric ad care, increased management of environmental factors and allergens, and the emergence of precision diagnostic tools.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp
Which Growth Drivers Are Shaping The Atopic Dermatitis Market Outlook?
Anticipated to surge forward is the growth of the atopic dermatitis market, due to the widespread prevalence of the disease. Atopic dermatitis, also known as eczema, manifests as dry, itchy skin. The escalating occurrence of atopic dermatitis prompts a growing need for its diagnosis and treatment. For example, Oxford Academic, a publishing company based in the UK, claims widespread global atopic dermatitis (AD) touching around 2.6% of the world’s population, or roughly 204 million people by 2024. This data includes approximately 101 million adults and 103 million children. Consequently, this growing prevalence of atopic dermatitis is propelling the expansion of the atopic dermatitis market.
How Is The Global Atopic Dermatitis Market Broken Down By Segment?
The atopic dermatitismarket covered in this report is segmented –
1) By Drug Class: Corticosteroids; Emollients Or Moisturizers; IL-4 And PDE4 Inhibitors; Calcineurin Inhibitors; Antibiotics; Other Drug Classes
2) By Mode of Administration: Topical; Injectable; Oral
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Systemic Corticosteroids
2) By Emollients Or Moisturizers: Creams and Lotions; Ointments and Balms; Barrier Repair Creams
3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor); Apremilast (PDE4 Inhibitor)
4) By Calcineurin Inhibitors: Tacrolimus Ointment; Pimecrolimus Cream
5) By Antibiotics: Topical Antibiotics; Systemic Antibiotics
6) By Other Drug Classes: Antihistamines; Biologics; JAK Inhibitors
Which Market Trends Are Expected To Define The Future Of The Atopic Dermatitis Market?
One prominent trend emerging in the atopic dermatitis market is the creation and launch of innovative products by renowned companies. These initiatives stimulate the companies’ stronghold in the market. As an illustrative case, Regeneron Pharmaceuticals Inc., a pioneering biotechnology firm in the US, earned FDA approval in June 2022 for its offering – Dupixent (dupilumab). Catering to moderate to severe cases of atopic dermatitis in children ranging from 6 months to 5 years, Dupixent can be combined with topical corticosteroids or used separately. The modus operandi of Dupixent is to obstruct signal of two prime sources of Type 2 inflammation (IL-4 and IL-13), that have key roles in onset of eosinophilic esophagitis, prurigo nodularis, chronic rhinosinusitis with nasal polyposis, and asthma.
Who Are The Primary Market Leaders In The Atopic Dermatitis Market?
Major companies operating in the atopic dermatitis market are Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan PLC, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report
Which Regional Markets Are Emerging As Key Hubs For The Atopic Dermatitis Market?
North America was the largest region in the atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8285&type=smp
Browse Through More Reports Similar to the Global Atopic Dermatitis Market 2025, By The Business Research Company
Dermatitis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report
Dermatology Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report
Dermatology Medical Lasers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model